Evofem Biosciences Secures $25 Million Strategic Investment from Adjuvant Capital
Amount Raised
$25 Million
Round Type
Corporate Round
San DiegoBiotechnologyDescription
Evofem Biosciences, Inc., (NASDAQ: EVFM) announced today that it has sold $25 million of unsecured convertible promissory notes to funds affiliated with Adjuvant Capital, LP ("Adjuvant Capital"). The notes are convertible into shares of Evofem common stock at a conversion price of $3.65 per share. Proceeds from the sale of the notes will be used to support EVOGUARD, Evofem's planned Phase 3 clinical trial of EVO100 for the prevention of urogenital chlamydia and gonorrhea in women, and to expand global market access for Phexxi™ (lactic acid, citric acid, potassium bitartrate) vaginal contraceptive gel.
Quick answer
Evofem Biosciences raised $25 Million in a Corporate Round round, dated October 15, 2020. Evofem Biosciences is based in San Diego, California, United States.
- How much did Evofem Biosciences raise?
- Evofem Biosciences raised $25 Million in a Corporate Round round on October 15, 2020.
- What does Evofem Biosciences do?
- Evofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health.
- Where is Evofem Biosciences based and how big is it?
- Evofem Biosciences is based in San Diego, California, United States.
- Who are the decision-makers at Evofem Biosciences?
- Fundz holds 1 contact at Evofem Biosciences, including the Global Distribution. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Evofem Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Kit Company, Inc. raised $2.5M (Seed) on November 27, 2020.
- ProtoKinetix raised $44K on November 27, 2020.
- Reprise Biomedical raised $2.8M on November 25, 2020.
- Metagenomi Therapeutics, Inc. raised $38M on November 25, 2020.
- Photomedics raised $2.3M (Seed) on November 24, 2020.
- PionEar Technologies, Inc. raised $50K (Pre-Seed) on November 24, 2020.
Who to call at Evofem Biosciences, and when
A new round usually means Evofem Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Evofem Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Evofem Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Evofem Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Evofem Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Evofem Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.